Routine colonoscopy in patients with high risk of non-occlusive mesenteric ischemia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Intensive care medicine. - 50, 7 (2024) , 1204-1205, ISSN: 1432-1238
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2024
- DOI
-
10.1007/s00134-024-07483-8
- URN
-
urn:nbn:de:bsz:25-freidok-2491211
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:42 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
Entstanden
- 2024
Ähnliche Objekte (12)
Non-occlusive mesenteric ischemia: the wolf in sheep’s clothing
Zellzyklus regulierende Funktion der Mammalian-STE20-like-Kinase-1 (MST1)
Zellzyklus regulierende Funktion der Mammalian-STE20-like-Kinase-1 (MST1)
Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP)—a single center, open-label, three-arm, randomized, controlled intervention trial
Correction: Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP) - a single center, open-label, three-arm, randomized, controlled intervention trial
Cytokine adsorption in patients with acute‐on‐chronic liver failure (CYTOHEP) — Aasingle center, open‐label, three‐arm, randomized, controlled intervention pilot trial
Prediction of survival among patients receiving transarterial chemoembolization for hepatocellular carcinoma : : a response‐based approach
HCC-Biomarker in der Diagnostik und Therapie des Hepatozellulären Karzinoms (HCC) in verschiedenen Phasen der Erkrankung
Practical considerations on hypoxemia and hypoxia in V-V ECMO patients
Comment on : : Extracorporeal hemoadsorption in critically ill COVID‑19 patients on VV ECMO
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC
Non-occlusive mesenteric ischemia: the wolf in sheep’s clothing
Zellzyklus regulierende Funktion der Mammalian-STE20-like-Kinase-1 (MST1)
Zellzyklus regulierende Funktion der Mammalian-STE20-like-Kinase-1 (MST1)
Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP)—a single center, open-label, three-arm, randomized, controlled intervention trial
Correction: Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP) - a single center, open-label, three-arm, randomized, controlled intervention trial
Cytokine adsorption in patients with acute‐on‐chronic liver failure (CYTOHEP) — Aasingle center, open‐label, three‐arm, randomized, controlled intervention pilot trial
Prediction of survival among patients receiving transarterial chemoembolization for hepatocellular carcinoma : : a response‐based approach
HCC-Biomarker in der Diagnostik und Therapie des Hepatozellulären Karzinoms (HCC) in verschiedenen Phasen der Erkrankung
Practical considerations on hypoxemia and hypoxia in V-V ECMO patients
Comment on : : Extracorporeal hemoadsorption in critically ill COVID‑19 patients on VV ECMO
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma
Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC
Non-occlusive mesenteric ischemia: the wolf in sheep’s clothing
Zellzyklus regulierende Funktion der Mammalian-STE20-like-Kinase-1 (MST1)
Zellzyklus regulierende Funktion der Mammalian-STE20-like-Kinase-1 (MST1)
Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP)—a single center, open-label, three-arm, randomized, controlled intervention trial
Correction: Cytokine adsorption in patients with acute-on-chronic liver failure (CYTOHEP) - a single center, open-label, three-arm, randomized, controlled intervention trial
Cytokine adsorption in patients with acute‐on‐chronic liver failure (CYTOHEP) — Aasingle center, open‐label, three‐arm, randomized, controlled intervention pilot trial
Prediction of survival among patients receiving transarterial chemoembolization for hepatocellular carcinoma : : a response‐based approach
HCC-Biomarker in der Diagnostik und Therapie des Hepatozellulären Karzinoms (HCC) in verschiedenen Phasen der Erkrankung
Practical considerations on hypoxemia and hypoxia in V-V ECMO patients
Comment on : : Extracorporeal hemoadsorption in critically ill COVID‑19 patients on VV ECMO
Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma